Podcasts about science university

We have a classic episode for you.. Conquer the art of managing patients with iron deficiency anemia. We are joined by the amazing Dr. Tom DeLoughery, @Bloodman (Oregon Health & Science University). Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Rapid fire questions/Picks of the Week Case History and Physical Laboratory Findings Management of Iron Deficiency Anemia Diet Oral Supplementation Unexplained Iron Deficiency Case 2 IV Iron Supplementation IV iron reactions Case 3 Laboratory Follow Up Post Supplementation When to Refer to a Hematology/Oncology specialist? Outro Credits Producer,Writer, Show Notes, Cover Art, and Infographics: Sai S Achi  MD MBA FACP  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Leah Witt, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Dr. Tom DeLoughery MD, MACP, FAWM Sponsor: FIGS Just go to WearFIGS.com and use code FIGSRX for 15% off  Sponsor: Uncommon Goods  To get 15% off your next gift, go to UNCOMMONGOODS.com/curb Sponsor: Continuing Education Company Visit CMEmeeting.org/curbsiders and use promo code Curb30 to get 30% off all online courses and webcasts—just for Curbsiders listeners.

This episode explores the essentials of effective doctor-patient communication in today's rapidly changing healthcare landscape, particularly in an era influenced by “Dr. Google” and increased patient access to information. Dr. Katie Schabel, Professor of Orthopaedic Surgery at Oregon Health and Science University, draws from her experience as both a clinician and educator to discuss practical strategies for building trust, demonstrating empathy, and fostering shared decision-making with patients. Topics include the “four E's” of communication - engage, empathize, educate, and enlist - as well as tips for tackling complex conversations around surgical risks, optimization, and misinformation found online. Host: Robert Orfali, MD, Editor in Chief, AAOS NowGuest: Katie Schabel, MD, Professor of Orthopaedic Surgery, Oregon Health and Science University

Episode Description:  Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication?  Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis. Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered. The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments.   Timestamps: (0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes. (1:15) In general, what is a vaccine and how it works in the body. (2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are         on treatments that influence the immune system. (4:53) The difference between live and non-live vaccines.   (8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and             specific medications for psoriatic disease, including a definition of medication half-lives. (13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic. (18:27) The mRNA vaccine – how it works in comparison to other vaccines. (22:31) How long immunity lasts from childhood vaccines. (25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances.      (28:38) Which healthcare provider to turn to for advice about vaccines and why. (31:54) Questions to ask your health care provider about vaccines. (33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific             medications and the need for greater understanding. (36:44) Develop a good relationship with your health care provider and don't be afraid to ask                 questions about your psoriatic disease, vaccines, or specific medications. Key Takeaways: ·       Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines.   ·       Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics.   ·       It's important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing  with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist.    Guest Bio: Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements. Resources:         “Does Having Psoriatic Disease Impact Vaccine Choices?” Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania).       Medical Board Clinical Statements                

Imaginez un peu : transformer de simples cellules de peau en ovule.Imagine that: transforming simple skin cells into egg cells.Ouais.Yeah.Et qu'ils puissent être fécondés.And that they can be fertilized.C'est la prouesse que des chercheurs expliquent dans Nature Communications.This is the feat that researchers explain in Nature Communications.C'est potentiellement énorme pour l'infertilité mais ça soulève de sacrées questions.It's potentially huge for infertility but it raises some serious questions.Alors, premier point : la science derrière tout ça.So, first point: the science behind all this.L'équipe de Paula Amato de l'Oregon Health and Science University, eh bien elle a réussi à créer ces ovocytes humains fonctionnels.The team of Paula Amato from the Oregon Health and Science University, well, they succeeded in creating these functional human egg cells.Ils ont même pu être fécondés par des spermatozoïdes.They could even be fertilized by sperm.Bon, ça a donné des embryons, mais ils avaient des anomalies, alors ils ont été détruits, hein.Well, it resulted in embryos, but they had abnormalities, so they were destroyed, you know.Les idées d'application, il y en a : traiter certaines infertilités, permettre aux couples de même sexe d'avoir des enfants génétiquement liés ou pallier le manque de don de gamètes, un vrai sujet en France par exemple.There are ideas for application: treating certain infertilities, allowing same-sex couples to have genetically related children or compensating for the lack of gamete donation, a real issue in France, for example.Mais, attention, hein, Paula Amato le répète, on parle de moins d'une décennie avant d'imaginer utiliser ça en clinique.But, be careful, Paula Amato repeats it, we're talking about less than a decade before considering using this in a clinical setting.On en est vraiment qu'au tout début.We are really only at the very beginning. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Amanda L. Clark, MD, MCR, MSCP, Professor Emerita,Obstetrics and Gynecology, Oregon Health & Science University; Senior Affiliate Investigator, Kaiser Permanente Center for Health Research; MSCP =Menopause Society Certified PractitionerCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ahXDmm5UC5⁠⁠ (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 30, 2025End Date: September 30, 2026

Amanda L. Clark, MD, MCR, MSCP, Professor Emerita,Obstetrics and Gynecology, Oregon Health & Science University; Senior Affiliate Investigator, Kaiser Permanente Center for Health Research; MSCP =Menopause Society Certified PractitionerCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ahXDmm5UC5⁠⁠ (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 30, 2025End Date: September 30, 2026

Dr. Mohammed Osman, the newest member of Advanced Cardiovascular Specialists (ACS), brings a depth of experience to this week's “Heart to Heart” podcast. His journey began with training at Michigan State, Oregon Health and Science University, and Yale University. He followed that training by leading the Endovascular Clinic at Mayo Clinic before joining ACS in […] The post Osman Intro first appeared on Advanced Cardiovascular Specialists.

Some people living with MS adhere to a treatment plan based exclusively on what we might consider traditional medicine. Others opt for alternative treatments. And, still, others take a whole-person health approach, blending integrative medicine with traditional treatments designed to support an individual's mind and body. Dr. Lynne Shinto joins me to discuss how a whole-person health approach can transform living with MS. Dr. Shinto is a Professor of Neurology and an MS Specialist at the Center for Women's Health at Oregon Health and Science University.   We're also sharing some encouraging news about funding for the National Institutes of Health in 2026. We'll explain the research that has led to the identification of a new and quite different subtype of MS.  We'll tell you about this year's winner of the Rachel Horne Prize for Women's Research in Multiple Sclerosis. The National MS Society's virtual program, New to MS: Navigating Your Journey, takes place in just two days. We have all the details! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: A whole-person health approach to MS care  :22 House Republicans reject President Trump's $20 billion cut to 2026 NIH funding  1:26 Have researchers identified a new MS subtype?  4:16 This year's winner of the Rachel Horne Prize for Women's Research in Multiple Sclerosis   8:27 We're two days away from the National MS Society's New to MS: Navigating Your Journey virtual program  9:53 Dr. Lynne Shinto discusses how taking a whole-person approach to MS care can transform your MS journey 12:04 Share this episode  31:41 Next week's episode   32:01 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/419 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com PARTICIPATE: Take the Shaping Tomorrow Together Survey https://s.alchemer.com/s3/Perspectives-on-MS REGISTER: Attend the virtual Shaping Tomorrow Together meeting with the FDA https://nmss.quorum.us/event/25463 SIGN UP: Become an MS Activist https://nationalmssociety.org/advocacy STUDY: Large-Scale Online Assessment Uncovers a Distinct Multiple Sclerosis Subtype with Selective Cognitive Impairment https://nature.com/articles/s41467-025-62156-4 REGISTER: New To MS: Navigating Your Journey https://nationalmssociety.org/understanding-ms/newly-diagnosed/new-to-ms-journey Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 419 Guest: Dr. Lynne Shinto Privacy Policy

In this episode, Dio Sumagaysay, Vice President of Perioperative and Multi-Specialty Procedural Services at Oregon Health & Science University, shares how his team is using iQueue for Operating Rooms' Staff Planner tool by LeanTaaS to streamline staffing across 54 operating rooms and procedural areas. He highlights the time savings, efficiency gains, and improvements in staff morale achieved through data-driven scheduling.This episode is sponsored by LeanTaaS.

Welcome back our series on AI for the clinician! In this episode, we go over some basics of machine learning statistics with the goal to help you read and analyze contemporary studies. Some of this will be a review, and parts will be technical, but by the end we hope reading these studies is less daunting.  Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-4 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery.  Julie Doberne, MD, PhD: @juliedoberne Julie Doberne is an Assistant Professor of Surgery, Assistant Professor of Medical Informatics and Clinical Epidemiology, cardiothoracic surgeon, and faculty member of the Surgical Data and Decision Sciences Lab at Oregon Health and Science University.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-4 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics.  Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology.  Shelby Willis, MD Shelby Willis is a general surgery PGY-4 at Oregon Health and Science University. She is currently in her research time in the Surgical Data and Decision Sciences lab at OHSU pursuing advanced training in informatics. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen BTK Fan Favorites:  General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Guest: Thomas DeLoughery, MD Host: Peter Buch, MD, FACG, AGAF, FACP Iron deficiency anemia is common in gastroenterology patients and is often underrecognized or suboptimally managed. That's why targeted treatment is essential to improve patient outcomes. In this expert-led discussion, Dr. Peter Buch and Dr. Thomas DeLoughery outline what gastroenterologists need to know about oral vs IV iron, absorption dynamics, and tailoring therapy for various patient populations. Dr. DeLoughery is a Professor of Medicine in the Division of Hematology and Oncology at Oregon Health and Science University in Portland.

In this episode, we're joined by Dr. Helané Wahbeh, Director of Research at the Institute of Noetic Sciences (IONS). In this conversation, we explore the frontier of human consciousness, intention, and our innate capacities that extend beyond the five senses. From the origins of IONS—founded by Apollo 14 astronaut Edgar Mitchell after a life-changing transcendent experience in space—to the cutting-edge research being conducted today, this episode uncovers how science is beginning to validate what many have experienced: the interconnectedness of all life.   INOS research applies the rigours of the scientific method to Psi Phenomena, including intuition, telepathy, remote viewing, and channelling. We examine how belief and meditation enhance these abilities, the role of genetics in psychic potential, and how technology may influence or diminish our innate human sensitivities.   This is a thought-provoking dialogue for anyone curious about bridging science and spirituality, and about unlocking the extraordinary possibilities that lie within. A vision for humanity on the edge of rediscovering the deeper magic of what it means to be human.   About the Institute of Noetic Sciences (IONS) The Institute of Noetic Sciences (IONS) is a nonprofit organisation founded in 1973 by Apollo 14 astronaut Dr. Edgar Mitchell after his transformative experience in space. IONS conducts scientific research, educational programs, and community initiatives to explore consciousness, human potential, and the interconnectedness of all life. For over 50 years, the institute has been pioneering studies at the intersection of science and spirituality, with a mission to advance understanding of our inner capacities and their impact on the world.   About Dr. Helané Wahbeh Dr. Helané Wahbeh is the Director of Research at the Institute of Noetic Sciences and an adjunct assistant professor in the Department of Neurology at Oregon Health & Science University. Trained as a naturopathic physician and clinical researcher, her work bridges rigorous science with the exploration of consciousness and human potential. She has published extensively on mind-body medicine, meditation, and noetic experiences such as channelling, intuition, and psychic phenomena. Helané is passionate about bringing credibility and scientific inquiry to topics often overlooked by mainstream research, helping to validate and expand humanity's understanding of its innate capacities.   Feelings with Strangers Socials Insta: https://www.instagram.com/feelings.with.strangers/ YouTube: https://www.youtube.com/@FeelingswithStrangers   IONS Site: https://noetic.org/ Insta: https://www.instagram.com/ionsonline/ X: https://x.com/IONSonline YouTube: https://www.youtube.com/c/InstituteofNoeticSciences   

The Food and Drug Administration approved the sale of over-the-counter birth control pills two years ago. The decision has dramatically increased access to contraception, according to a new study from Oregon Health & Science University.    Researchers found that more than a quarter of participants who were using the over-the-counter pill had switched from using no birth control at all. They also found that members of the over-the-counter group were more likely to be uninsured and live in rural areas than participants who used prescription birth control.   Maria Rodriguez is the director of both the Center for Reproductive Health Equity and the Center for Women’s Health at OHSU. She joins us with more on the importance of removing barriers to reproductive health care.  

Phil and Penny Knight have pledged $2 billion to Oregon Health & Science University for cancer research. The Knight Cancer Institute will become self-governed within OHSU and will have its own board of directors. In December, renowned cancer researcher Brian Druker announced his resignation as the institute’s CEO but said last week he will return as the inaugural president of the organization. He joins us with details about what this means for cancer care in Oregon.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jacqueline Wong, MD, MSCR, FACOG For patients with endometriosis, treatment delays can profoundly impact both quality of life and clinical outcomes. Proactive strategies that address logistical barriers—such as prior authorizations—combined with education and multidisciplinary support are essential in improving care. Join Dr. Charles Turck and Dr. Jacqueline Wong as they explore practical approaches for managing this complex condition and navigating potential hurdles. Dr. Wong is a minimally invasive gynecologic surgeon and an Assistant Professor of Obstetrics and Gynecology in the School of Medicine at Oregon Health and Science University in Portland.

Around one in 10 youth enrolled in Medicaid spent days stuck in the emergency room after being admitted for a mental health crisis. That’s according to a new study from Oregon Health and Science University. John McConnell is a professor in emergency medicine and the director of the center for health systems at OHSU. Rebecca Marshall is a professor in child and adult psychiatry with OHSU. She is also a practicing psychiatrist at Doernbecher Children's Hospital and Doernbecher emergency department. They both join us to share more on the study and what it means for the kids waiting to be admitted.

The 5 things you need to know before the stock market opens today: President Trump will meet Vladimir Putin in Alaska to discuss a Russia-Ukraine truce, China's economy slowed in July, Japan's economy grew more than expected, Air Canada expects to cancel hundreds of flights ahead of a strike, and Nike Co-Founder Phil Knight donates $2B to Oregon Health and Science University. Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format. 

In this episode, Prof Chris Vorster (Director, Centre for Human Metabolomics, North-West University, South Africa), Sarah Viall (Assistant Professor, Molecular and Medical Genetics, Oregon Health & Science University, USA) and PD Dr. med. Ulrike Mütze (Consultant, Heidelberg University Hospital, Germany) join Silvia Radenkovic and Rodrigo Starosta to explore the evolving landscape of newborn screening. They discuss national and international variations in practice, how to maintain consistency and quality, and the future scope of testing – including opportunities to improve access in resource-limited settings. Authors' opinions are their own and do not represent their institutions. Referenced papers include: Newborn screening in South Africa: the past, present, and plans for the future. Malherbe et al (2024) Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. McHugh et al (2024) Five years of newborn screening for Pompe, Mucopolysaccharidosis type I, Gaucher, and Fabry diseases in Oregon. Viall & Held (2025) Long-term outcomes of adolescents and young adults identified by metabolic newborn screening. Mütze et al (2025) Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn Screening. Mengler et al (2024) Vitamin B12 Deficiency Newborn Screening. Mütze et al (2024) The role of exome sequencing in newborn screening for inborn errors of metabolism. Adhikari et al (2020)

Send us a textWhat happens if you need your third molars removed? Cosmo and I find out, after talking to our friend David Carsten. He's a dentist anesthesiologist who studied at Washington State University and now teaches at Oregon Health and Science University.Find out the real tooth here.Resources you can use:Find out what it's like to be a dentist, a dental hygienist or a dental assistant, thanks to Teeth Talk GirlLearn more about early humans' big jaws with Ted-EdGet the official word on wisdom teeth from the American Dental AssociationSound effects courtesy Zapsplat and Pixabay As always, submit burning questions at askdruniverse.wsu.edu. Who knows where your questions will take us next.

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/sociology

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

When Christa Kuljian arrived on the Harvard College campus as a first-year student in the fall of 1980 with copies of Our Bodies, Ourselves and Ms. magazine, she was concerned that the women's movement had peaked in the previous decade. She soon learned, however, that there was a long way to go in terms of achieving equality for women and that social movements would continue to be a critical force in society. She began researching the history of science and gender biases in science, and how they intersect with race, class, and sexuality. In Our Science, Ourselves: How Gender, Race, and Social Movements Shaped the Study of Science (University of Massachusetts Press, 2024), Kuljian tells the origin story of feminist science studies by focusing on the life histories of six key figures--Ruth Hubbard, Rita Arditti, Evelyn Fox Keller, Evelynn Hammonds, Anne Fausto-Sterling, and Banu Subramaniam. These women were part of a trailblazing network of female scientists in the 1970s, 80s, and 90s who were drawn to the Boston area--to Harvard, MIT, and other universities--to study science, to network with other scientists, or to take a job. Inspired by the social and political activism of the women's movement and organizations such as Science for the People, the Genes and Gender Collective, and the Combahee River Collective, they began to write and teach about women in science, gender and science, and sexist and racist bias and exclusion. They would lead the critiques of E. O. Wilson's sociobiology in 1975 and Larry Summers' comments about women in science thirty years later. Drawing on a rich array of sources that combines published journal articles and books with archival materials and interviews with major luminaries of feminist science studies, Kuljian chronicles and celebrates the contributions that these women have made to our collective scientific knowledge and view of the world. Christa Kuljian grew up in the Boston area, and has lived in Johannesburg, South Africa for the past thirty years. She is a science writer and the author of Sanctuary and Darwin's Hunch: Science, Race and the Search for Human Origins, which was short listed for the Sunday Times Alan Paton Award for Non-Fiction. Currently a Research Associate at the Wits Institute for Social and Economic Research (WiSER) at Wits University, she is also a fellow with the Consortium for History of Science, Medicine and Technology (CHSMT) in Philadelphia. Caleb Zakarin is editor of the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

In the eighth episode of season 4, special host Dr. Cara English, Chief Executive Officer (CEO) and Chief Academic Officer (CAO) of Cummings Graduate Institute for Behavioral Health Studies (CGI), sits down with Dr. David Clarke, President and Co-Founder of the Association for the Treatment of Neuroplastic Symptoms. Together, they look into the emerging science of neuroplastic pain, which are chronic symptoms caused by learned neural pathways in the brain rather than disease or injury. Dr. Clarke shares how these misunderstood conditions are being redefined through the lens of mind-body medicine. Tune in to explore how neuroplasticity is reshaping our understanding of chronic illness.About the Special Host:Dr. Cara English, DBH is the Chief Executive Officer and Chief Academic Officer of Cummings Graduate Institute for Behavioral Health Studies (CGI) and Founder of Terra's Tribe, a maternal mental health advocacy organization in Phoenix, Arizona. Dr. English spearheaded a perinatal behavioral health integration project at Willow Birth Center from 2016 to 2020 that received international acclaim through the publication of outcomes in the International Journal of Integrated Care. Dr. English served as Vice-President of the Postpartum Support International – Arizona Chapter Founding Board of Directors and co-chaired the Education and Legislative Advocacy Committees. She currently serves on the Maternal Mortality Review Program and the Maternal Health Taskforce for the State of Arizona. She served as one of three Arizonan 2020 Mom Nonprofit Policy Fellows in 2021. For her work to establish Cummings Graduate Institute for Behavioral Health Studies, Cara was awarded the Psyche Award from the Nicholas & Dorothy Cummings Foundation in 2018 and is more recently the recipient of the 2022 Sierra Tucson Compassion Recognition for her work to improve perinatal mental health integration in Arizona.About the Guest:David D. Clarke, MD is President of the Association for Treatment of Neuroplastic Symptoms, and Clinical Assistant Professor of Gastroenterology Emeritus at Oregon Health & Science University in Portland, Oregon.  He is board-certified in Gastroenterology and Internal Medicine and has treated over 7000 patients whose symptoms were not explained by disease or injury but rather by stress or trauma. His book for patients, They Can't Find Anything Wrong!, was praised by a president of the American Psychosomatic Society as “truly remarkable.” He has also edited two textbooks on stress-based conditions, co-produced three documentary films, lectures across North America and Europe and has done hundreds of interviews for TV, Radio, and podcasts.www.Symptomatic.me 

What if your persistent unexplained chronic pain or illness isn't just physical? Neuroplastic symptoms describe chronic pain or illness that defies conventional medical explanations, and Dr. David D. Clarke, a pioneering expert in neuroplastic symptoms and mind-body healing, has dedicated his career to uncovering the profound links between stress, grief, trauma, and physical symptoms. As President of the Association for Treatment of Neuroplastic Symptoms, and Clinical Assistant Professor of Gastroenterology and Americans at Oregon Health and Science University, Dr. Clarke shares invaluable insights on common neuroplastic conditions, personal traits linked to these symptoms, and how they can be effectively diagnosed and treated, offering hope and highlighting the possibility of healing for those struggling with chronic pain or illness who have been told "they can't find anything wrong."WATCH ON YOUTUBE: Can Unexplained Chronic Pain Be Linked to Grief, Trauma, and Stress?IN THIS EPISODE, YOU'LL HEAR ABOUT THINGS LIKE:How unresolved emotional distress can manifest as chronic pain or illness.Common neuroplastic conditions and personal traits linked to these symptoms.The five common types of stress that are emotionally painful experiences.How neuroplastic symptoms can be effectively diagnosed and treated.The concept of stress illness and its evolution into a widespread epidemic.The difference between visible and invisible illnesses and the importance of listening without judgment.The "neuroplastic self-quiz" and its purpose.The importance of finding joy in life and aligning skills with what the world needs.Grab Dr. Clarke's They Can't Find Anything Wrong!: 7 Keys to Understanding, Treating, and Healing Stress IllnessBecome a member of ATNS: https://www.symptomatic.me/membership---✨ Grief & Rebirth: Healing Resources & Tools ✨

At the 2025 Patient Access Collaborative Symposium, Stephanie Schmidt, MS, Senior Director of Ambulatory Operations, and Adam Stone, MS, Director of Clinical Data & Analytics of Oregon Health & Science University led a high-impact workshop on building a culture of data fluency and accountability in access operations. As leaders in both operations and analytics, Stephanie and Adam shared real-world examples of how their teams are aligning key performance indicators (KPIs) with meaningful metrics, using dashboards to bring data to life, and building the infrastructure for consistent governance across departments. Their focus: turning insights into action—and making data not just visible, but transformative.In this episode, they reflect on the collective wisdom shared by access leaders nationwide—from the most common metrics (like fill rate and new patient lag) to the shared barriers (like attribution and cultural resistance). They also unpack the often-overlooked ROI of access initiatives, discuss how to improve organizational fluency, and share their aspirations for the future of access analytics. Whether you're launching a dashboard or leading enterprise-wide transformation, this conversation offers powerful takeaways to guide your next step.

Judy Guzman-Cottrill, DO, Professor of Pediatrics at Oregon Health & Science University, and John Brooks, MD, former CDC medical officer, rejoin Mati Hlatshwayo Davis, MD, MPH, FIDSA, to discuss the impact of federal funding cuts, including the return of preventable diseases, the loss of mental health resources, and what can be done to protect the progress made toward health equity.The IDSA Leadership Institute empowers infectious diseases and HIV practitioners to be future leaders. Crafted specifically by and for specialists in infectious diseases and HIV, the Leadership Institute offers two tailored leadership development pathways.Learn More

Welcome back to our series on AI for the clinician! Large language models, like ChatGPT, have been taking the world by storm, and healthcare is no exception to that rule – your institution may already be using them! In this episode we'll tackle the fundamentals of how they work and their applications and limitations to keep you up to date on this fast-moving, exciting technology. Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-3 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics. Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this two-part series, Judy Guzman-Cottrill, DO, Professor of Pediatrics, Division of Infectious Diseases at Oregon Health and Science University, and John Brooks, MD,  former CDC medical officer and epidemiologist, join Mati Hlatshwayo Davis, MD, MPH, FIDSA, to discuss the real-time consequences of federal funding cuts on public health. From dismantled community partnerships to stalled clinical trials, the three examine how these decisions are reshaping pandemic preparedness, and what we risk losing next.The IDSA Leadership Institute empowers infectious diseases and HIV practitioners to be future leaders. Crafted specifically by and for specialists in infectious diseases and HIV, the Leadership Institute offers two tailored leadership development pathways.Learn More

You're doing everything right. You're on hormones, you've cut the caffeine, maybe you've even bought one of those expensive sleep trackers. So why are you still waking up at 3am, wired and restless?In this episode, I sit down with Dr. Andrea Matsumura—board-certified sleep physician and women's health specialist—to finally unpack why sleep is such a persistent struggle for women, especially during perimenopause and menopause. Andrea breaks down the biological, psychological, and cultural reasons why women are conditioned to expect poor sleep—and why it doesn't have to be that way.We talk melatonin myths (the dose matters), the silent epidemic of undiagnosed sleep apnea in women, and why most wearables are only telling part of the story. Andrea also explains why cannabis, supplements, and even hormone therapy may help—but won't fix the root cause for many women.Plus, we get into the real reason cognitive behavioral therapy for insomnia (CBT-I) actually works—if you're willing to do the work—and how the entire medical system is failing women by ignoring gender-specific data in sleep studies and diagnostics.If you're tired of being tired and want real, practical answers—not just another supplement or influencer sleep hack—this conversation is for you.HighlightsWhy hormone therapy helps some women sleep—but not all.How sleep apnea presents differently in women and often goes undiagnosed.The truth about melatonin: why most people take the wrong dose at the wrong time.Cannabis and sleep: what the research really shows.Why CBT-I is the gold standard for insomnia (and why apps alone aren't enough).Do you like what you heard? Don't forget to subscribe, like, and leave a comment on Apple Podcasts your support helps us reach more listeners who deserve better answers.Guest Bio:Dr. Andrea Matsumura MD MS FACP FAASM is a board certified sleep specialist and menopause expert, event and corporate speaker, group facilitator, co-founder of the Portland Menopause Collective, and creator of the Sleep Goddess MD D.R.E.A.M. Sleep Method™ and Sleep Goddess Archetype™.Dr. Matsumura attended medical school at The University of Texas Health Science Center in San Antonio. She moved to Portland, Oregon for her residency in Internal Medicine and was an Internal Medicine Physician with Northwest Permanente for 13 years before entering her fellowship in Sleep Medicine. She attended Oregon Health and Science University as a fellow in Sleep Medicine. She became a partner at The Oregon Clinic in Pulmonary, Critical Care, and Sleep Medicine after completing her fellowship. During her tenure there she focused on women's health and became a sought-after expert on women and sleep. She is currently the Medical Director of primary care services and medical home development for Cascadia Health in Portland, Oregon and has plans to develop sleep services.Get in Touch with Dr. MatsumuraWebsiteInstagramGet in Touch with Dr. Rahman:WebsiteInstagramYoutube

Welcome to our new series – the AI Journal Club! In this series, we'll cover some interesting studies and evidence-based applications of artificial intelligence in surgery in a case-based format. Surely AI can find a DVT by now … or can it? Stay tuned and find out! Hosts: - Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. - Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  - Marisa Sewell, MD: @MarisaSewell Marisa Sewell is a general surgery PGY-4 at Oregon Health and Science University.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

S. R. Schulz lives in Portland, Oregon with his wife, three sons, and two dogs. He's been traveling to visit family in Croatia since 2010. He currently works as a family physician just outside Portland, Oregon, and is a faculty member at Oregon Health & Science University. His writing has been published online and in print, including McSweeney's, HAD, Rejection Letters, Maudlin House, Autofocus, and others. Supersymmetry is his first novel. Find him at srschulzwriting.com or at @authorseanschulz on instagram

 On Monday, Oregon Health and Science University and Legacy Health announced they are mutually walking away from an effort to combine the two healthcare organizations. The merger was first announced last August, when OHSU agreed to acquire 8 hospitals, $3 billion in assets and promised a whopping $1 billion in upgrades to Legacy facilities. The merger garnered scrutiny from a citizen review committee and public comments have reflected opposition to the deal. Amelia Templeton is OPB’s Healthcare reporter and has been following this story. She joins with the latest.

Non-cystic fibrosis (CF) bronchiectasis, which affects approximately a half million people in the US, is a chronic lung condition that involves permanent bronchial dilation and inflammation; it is characterized by a productive cough and recurrent exacerbations. Author Alan F. Barker, MD, of Oregon Health and Science University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss non-CF bronchiectasis. Related Content: Non–Cystic Fibrosis Bronchiectasis in Adults

S. R. Schulz lives in Portland, Oregon with his wife, three sons, and two dogs. He's been traveling to visit family in Croatia since 2010. He currently works as a family physician just outside Portland, Oregon, and is a faculty member at Oregon Health & Science University. His writing has been published online and in print, including McSweeney's, HAD, Rejection Letters, Maudlin House, Autofocus, and others. Supersymmetry is his first novel.  Find him at srschulzwriting.com or at @authorseanschulz on instagram 

On this month's installment of our Longevity Series, WHOOP Global Head of Human Performance, Principal Scientist, Dr. Kristen Holmes, sits down with Dr. Adrian Cois. Dr. Cois is an Australian-born Emergency Physician and Assistant Professor of Emergency Medicine, currently practicing in Portland, Oregon. Dr. Cois has an extensive background as a strength and conditioning coach, working with 5 professional Australian sports teams before completing his medical residency at Oregon Health and Science University. Dr. Cois joins the WHOOP podcast to discuss his TedX presentation on the cultural comparison of healthcare in Australia versus the United States and how this impacts longevity. Dr. Holmes and Dr. Cois discuss:(00:25) Dr. Cois's background in Medicine(01:47) Reframing Trauma in Emergency Care(05:26) Frontline Healthcare Workers' Challenges with Personal Health and Wellness (07:46) Cultural Differences between the US and Australia(10:28) Importance of Implementing Preventative Medicine (18:27) Areas for Improvement in the US Healthcare System(21:17) Best Methods to Motivate Individuals to Take Control of Their Health(25:29) The Existing Health Culture in Australia (30:04) Light Behavior and The Benefits of Time Spent Outside. (31:30) Lessons Americans Can Learn From Australians(33:58) Implementing Health Culture(35:12) The Relationship Between Sleep Quality and Shift Work (41:27) How Americans Can Improve Their Health (41:54) Habit Changes For Your Health Follow Dr. Adrian Cois:InstagramLinkedInSupport the showFollow WHOOP: www.whoop.com Trial WHOOP for Free Instagram TikTok X Facebook LinkedIn Follow Will Ahmed:Instagram X LinkedIn Follow Kristen Holmes: Instagram LinkedIn Follow Emily Capodilupo: LinkedIn

On the debut episode of the AMSSM Sports Medicine Primer Series (X: @TheAMSSM), host Dr. Stephen Luebbert, MD, MS, is joined by Dr. Jacqueline Brady, MD, to discuss how to manage a case of patellar dislocation in a basketball player. The goal of this new series is to be an audible study aid for anyone pursuing a career as a sports medicine physician and to prepare them for a sports medicine fellowship. Dr. Brady is an orthopedic sports medicine surgeon at Oregon Health & Science University in Portland, OR, where he is also the Associate Residency Program Director and Director of Orthopedic Simulation. Dr. Brady serves as Head Team Physician for Portland State University and performs research in the field of patellofemoral instability, multi-ligamentous knee injuries and arthroscopic skill-building in learners. Resources: Best Practices in Sports Medicine: AMSSM and AOASM Case Studies (2nd Edition): https://amssmstore.com/best-practices-in-sports-medicine-amssm-and-aoasm-case-studies-second-edition

Join us for an insightful conversation with Dr. Christine Tsai, a doctor, educator, and mentor whose career exemplifies excellence in medicine. Dr. Tsai is an associate professor of medicine and attending physician of hospital medicine at RUSH medical center. She completed her B.A. in biochemical sciences at Harvard, her M.D. at Columbia, and her residency in internal medicine at Oregon Health and Science University.Over her 12 years as a practicing physician, Dr. Tsai has demonstrated a devotion to medical education and clinical practice. She has served as the Director of Clinical Skills, Practitioner Role Leader, and the Internal Medicine Sub-Internship Co-Director, shaping both the preclinical and clinical curriculum at Rush Medical College. Dr. Tsai also embodies a passion for mentorship of numerous medical students, residents, and junior faculty members.Come along as the conversation merges from the technical to the philosophical.Host: Samantha ShihGuest: Christine (Steen) TsaiProduced By: Samantha ShihAlert & Oriented is a medical student-run clinical reasoning podcast dedicated to providing a unique platform for early learners to practice their skills as a team in real time. Through our podcast, we strive to foster a learning environment where medical students can engage with one another, share knowledge, and gain valuable experience in clinical reasoning. We aim to provide a comprehensive and supportive platform for early learners to develop their clinical reasoning skills, build confidence in their craft, and become the best clinicians they can be.Follow the team on X:A&OA fantastic resource, by learners, for learners in Internal Medicine, Family Medicine, Pediatrics, Primary Care, Emergency Medicine, and Hospital Medicine.

Oregon Health & Science University began its Long COVID-19 clinic in 2021, a year into the pandemic as the first vaccines were just becoming widely available. We talked with doctors in the clinic in 2022, and we wanted to check back in to see what clinicians have learned after treating thousands of long COVID patients. Aluko Hope is a pulmonologist, critical care doctor and the medical director of OHSU’s Long COVID-19 program. Jen Arnold is a lead nurse with the program. They both join us to tell us what they’ve learned about caring for patients with long COVID in the last four years and what they hope to learn more about from the research that’s currently underway.

In this episode of the Brain & Life Podcast, co-host Dr. Katy Peters is joined by journalist Kat McGowan. In 2022, Kat was awarded a fellowship from the Alicia Patterson Foundation to cover caregiving and has been featured in Wired, Popular Science, Scientific American, Boston Globe, Audubon, and NPR. Kat discusses her experience with caregiving for her parents and how technology like robots helped in the caregiving relationship. Dr. Peters is then joined by Dr. Jeffrey Kaye, professor of neurology and biomedical engineering at Oregon Health and Science University, director of Layton Aging and Alzheimer's Disease Center, and director of the Oregon Center for Aging and Technology. Dr. Kaye explains what Alzheimer's disease is and how different types of technology are used in treatment and caregiving scenarios.   Additional Resources My Parents' Dementia Felt Like the End of Joy. Then Came the Robots A Robotic Pet Brings Joy to a Patient Who Has Dementia Promising Advances in Robotics-assisted Rehabilitation Therapies Lynda Carter Advocates for Those with Alzheimer's Disease   Other Brain & Life Podcast Episodes Finding Community in Caregiving with Kitty Norton Navigating Complicated Caregiving Journeys with Jacquelyn Revere Journalist, Producer Kitty Eisele's Honest Recount of Her Time as Caregiver We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media: Kat McGowan @mcgowankat; Dr. Jeffrey Kaye @oshunews Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

Scientists at Oregon State University and Oregon Health and Science University have teamed up to find new ways to treat endometriosis, ovarian cancer and other health conditions using nanoparticles and magnetic fields. Joining us to tell us more about this fascinating research are OPB science reporter Jes Burns, who is also the host and producer behind the “All Science. No Fiction.” video series, and OPB cinematographer and editor Brooke Herbert. This episode was recorded with a live audience at the Tomorrow Theater in Portland.   You can see the video about the medical applications of magnetic nanoparticles here.   For more Evergreen episodes and to share your voice with us, visit our showpage. Follow OPB on Instagram, host Jenn Chávez and Oregon Field Guide. You can sign up for OPB’s newsletters to get what you need in your inbox regularly.   Don’t forget to check out our many podcasts, which can be found on any of your favorite podcast apps: Hush Timber Wars Season 2: Salmon Wars Politics Now Think Out Loud And many more! Check out our full show list here.

Cancer is not a singular disease but a category of hundreds, even thousands, of rare diseases with different molecular signatures and genetic roots. Cancer scientists are looking for a thousand perfect keys to pick a thousand stubborn locks. Today's episode is about the hardest lock of them all: pancreatic cancer. Cancer's power lives in its camouflage. The immune system is often compared to a military search and destroy operation, with our T cells serving as the expert snipers, hunting down antigens and taking them out. But cancer kills so many of us because it looks so much like us. Pancreatic cancer is so deadly in part because it's expert at hiding itself from the immune system. Now, here's the good news. This might be the brightest moment for progress in  pancreatic cancer research in decades—and possibly ever. In the past few years, scientists have developed new drugs that target the key gene mutation responsible for out of control cell growth. Recently, a team of scientists at Oregon Health and Science University claimed to have developed a blood test that is 85 percent accurate at early-stage detection of pancreatic cancer, which is absolutely critical given how advanced the cancer is by the time it's typically caught. And last month, a research center at Memorial Sloan Kettering published a truly extraordinary paper. Using mRNA technology similar to the COVID vaccines, a team of scientists designed a personalized therapy to buff up the immune systems of people with pancreatic cancer. Patients who responded to the treatment saw results that boggle the mind: 75 percent were cancer-free three years after their initial treatment. Not just alive, which would be its own minor miracle. But cancer-free. The mRNA vaccine, administered within a regimen of standard drugs, stood up to the deadliest cancer of them all and won. Today's guest is the head of that research center, the surgical oncologist Vinod Balachandran. The concept of a personalized cancer vaccine is still unproven at scale. But if it works, the potential is enormous. But again: Cancer does not exist, as a singular disease. Cancer is a category of rare diseases, many of which are exquisitely specific to the molecular mosaic of the patient. Cancers are personal. Perhaps in a few years, our cures for cancers will be equally personalized. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guest: Vinod Balachandran Producer: Devon Baroldi Links:  Cancer Vaccine paper: https://www.nature.com/articles/s41586-024-08508-4 P.S. Derek wrote a new book! It's called 'Abundance,' and it's about an optimistic vision for politics, science, and technology that gets America building again. Buy it here: https://www.simonandschuster.com/books/Abundance/Ezra-Klein/9781668023488 Plus: If you live in Seattle, Atlanta, or the Raleigh-Durham-Chapel Hill area, Derek is coming your way in March! See him live at book events in your city. Tickets here: The Abundance Book Tour Learn more about your ad choices. Visit podcastchoices.com/adchoices

An estimated 650,000 adults in Bangladesh suffer from blindness, according to researchers. At the end of November, Oregon Health & Science University ophthalmologist Beth Edmunds traveled to the country to teach local doctors a minimally-invasive operation for adults and children with glaucoma. She joins us to share what she took away from her time volunteering and what it was like operating in the world’s only flying teaching hospital. 

Conquer the art of managing patients with iron deficiency anemia. We are joined by the amazing Dr. Tom DeLoughery, @Bloodman (Oregon Health & Science University). Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Rapid fire questions/Picks of the Week Case History and Physical Laboratory Findings Management of Iron Deficiency Anemia Diet Oral Supplementation Unexplained Iron Deficiency Case 2 IV Iron Supplementation IV iron reactions Case 3 Laboratory Follow Up Post Supplementation When to Refer to a Hematology/Oncology specialist? Outro Credits Producer,Writer, Show Notes, Cover Art, and Infographics: Sai S Achi  MD MBA FACP  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Leah Witt, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Dr. Tom DeLoughery MD, MACP, FAWM Sponsor: Mint Mobile Shop plans at mintmobile.com/curb. Sponsor: Freed Visit freed.ai and use code CURB50 to get $50 off your first month when you subscribe! Sponsor: Quince Give yourself the luxury you deserve with Quince! Go to Quince.com/curb for free shipping on your order and 365-day returns.

Oregon Health & Science University has been facing a series of mounting challenges in recent months, including its proposed merger with Legacy Health, which is being reviewed by the Oregon Health Authority. If approved, OHSU would control five of the six hospitals in Multnomah County, according to a report issued by OHA last November.  OHSU has also had to contend with the departure of prominent executives such as the interim head of its health unit last month, and Dr. Brian Druker, a world renowned cancer researcher, who resigned in December as CEO of the Knight Cancer Institute. Among the reasons Druker shared with OPB for his decision included low staff morale, a lack of trust in OHSU’s leaders and the organization’s cost-cutting measures, such as its decision to lay off more than 500 employees.  Leading OHSU during this turbulent time is Steve Stadum. The board of directors appointed him as interim president in November, marking his return to the organization which he first worked at more than 25 years ago. Stadum joins us to share his vision for OHSU and how he aims to navigate its internal and external challenges, including threats to federally funded research from the new Trump administration.  

Animals such as grizzly bears and Arctic ground squirrels have evolved the ability to hibernate as a way to survive winter months of extreme cold. During hibernation, their core body temperatures drop and their heart rates and metabolic activities slow to conserve energy. They also consume less oxygen during this inactivity.    But what if you could make non-hibernating species – including humans - hibernate? How could you control hibernation as a therapy to help people recover from strokes or heart attacks, or administer it to astronauts to help them endure a yearslong trip to Mars? Scientists at Oregon Health & Science University have embarked on a first step to exploring these questions by inducing a state of hibernation in rats, which don’t normally hibernate. Joining us to discuss this research is Domenico Tupone, a research assistant professor of neurology at OHSU.

According to the CDC, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or death if left untreated. Injection drug use is the leading risk factor for hepatitis C, which is also more prevalent in rural counties where diagnosis and treatment can be hard to come by, especially for people experiencing homelessness.  Scientists at Oregon Health and Science University demonstrated a new strategy that could significantly boost the diagnosis and successful treatment of hepatitis C in rural communities. In a recently published study, they showed that peers with lived experience in drug use were able to successfully enroll and facilitate treatment for people who tested positive for hepatitis C in six rural Oregon counties using telemedicine, which was seven times more effective than referrals to clinics for in-person treatment. Joining us to talk about the results and the role peer specialists can play to combat the spread of hepatitis C is Dr. Andrew Seaman, an associate professor of medicine at OHSU, the medical director of HIV and hepatitis C services at Central City Concern and head of substance use disorder programs at Better Life Partners in New England.